News & Analysis as of

Generic Drugs Infringement

Axinn, Veltrop & Harkrider LLP

Federal Circuit Provides Useful Guidance on Skinny Label Claims

When the Federal Circuit resurrected Amarin’s “skinny label” infringement claims against Hikma last month, it offered some important lessons for drug developers. The precedential decision helps clarify the kinds of...more

MoFo Life Sciences

Skinny Labels Back In Focus After HHS Report On Addressing Drug Prices

MoFo Life Sciences on

Skinny labels are back in focus at the White House. On September 9, 2021, the U.S. Department of Health and Human Services submitted its much-anticipated report to the White House Competition Counsel regarding a...more

McDonnell Boehnen Hulbert & Berghoff LLP

G.D. Searle LLC v. Lupin Pharmaceuticals, Inc. (Fed. Cir. 2015)

Over seven years ago, the Federal Circuit delivered a mixed ruling against Pfizer in litigation against Teva) relating to the pain medication Celebrex® (celocoxib) (where "celocoxib" is...more

Foley & Lardner LLP

Federal Circuit Finds “Molecular Weight” to Be Insolubly Ambiguous

Foley & Lardner LLP on

In Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., the Federal Circuit invalidated a number of claims directed to a polymer defined by its “molecular weight” because the term was ambiguous, and Applicants’ conflicting...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- June 23, 2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Alza Corp. et al. v. Par Pharmaceutical Inc. et al. 1:13-cv-01104; filed June 19, 2013 in the District Court of Delaware...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- May 19, 2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AbbVie Inc. v. Hetero USA Inc. et al. 1:13-cv-00852; filed May 15, 2013 in the District Court of Delaware - •...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report - May 05, 2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eisai R&D Management Co., Ltd. v. Rea - 1:13-cv-00548; filed May 2, 2013 in the Eastern District of Virginia: ...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report - April 28, 2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Mayo Foundation for Medical Education and Research v. ARUP Laboratories, Inc. - Infringement of U.S. Patent Nos....more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- April 1, 2013

In This Issue: Millennium Pharmaceuticals Inc. v. Fresenius Kabi USA LLC et al.; Trustee's of the University of Pennsylvania v. St. Jude Children's Research Hospital; and Pfizer Inc. et al. v. Lupin Ltd. et al.....more

McDermott Will & Emery

Supreme Court Hears Oral Argument in "Pay-for-Delay" Patent Settlement Antitrust Case

McDermott Will & Emery on

The Supreme Court’s ruling in Federal Trade Commission v. Actavis, Inc., will almost certainly have major implications for the viability of Federal Trade Commission and private suits alleging that pay-for-delay settlements...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- March 24, 2013

In This Issue: AstraZeneca AB et al. v. Watson Laboratories, Inc. - Florida et al.; Pharmacia & Upjohn Co. LLC et al. v. Apotex, Inc. et al.; Intendis GmbH et al. v. Glenmark Generics Ltd. et al.; and Boehringer...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- March 17, 2013

In This Issue: Apotex, Inc. et al. v. Teva Pharmaceutical Industries, Ltd. et al.; Bayer Intellectual Property GmbH et al. v. Rea; Janssen Products, L.P. et al. v. Hetero Drugs, Ltd. et al.; Novartis Pharmaceuticals...more

McDonnell Boehnen Hulbert & Berghoff LLP

New from Abroad: Broadening of UK Bolar Defence

Originally published in WP Thompson & Co. on March 4, 2013. On 26 February 2013, the UK government announced a proposed change to the Patents Act to exempt clinical and field trials, as well as "health technology...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- February 24, 2013

In This Issue: Novartis Pharmaceuticals Corp. v. Actavis LLC et al.; Precision Biosciences Inc. et al. v. Cellectis S.A. et al.; Bayer Pharma AG v. Warner Chilcott Co., LLC et al.; Promega Corp. et al. v. Life...more

McDonnell Boehnen Hulbert & Berghoff LLP

Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Fed. Cir. 2013)

Whether ANDA litigation has had a positive or negative impact on generic drug availability is an open question, in view of several recent reports looking at the effects such litigation has had on both branded and generic...more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- February 10, 2013

In This Issue: Cadence Pharmaceuticals, Inc. et al. v. Sandoz Inc.; Cadence Pharmaceuticals, Inc. et al. v. Sandoz, Inc.; Purdue Pharma L.P. et al. v. Watson Laboratories, Inc. et al.; Purdue Pharma L.P. et al. v....more

McDonnell Boehnen Hulbert & Berghoff LLP

Court Report -- January 27, 2013

Hoffmann-La Roche Inc. et al. v. Aurobindo Pharma Ltd. et al. - 1:13-cv-00124; filed January 22, 2013 in the District Court of Delaware • Plaintiffs: Hoffmann-La Roche Inc.; Genentech Inc. • Defendants: ...more

17 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide